Is there any association between plasma lipid profile and severity of COVID-19?

Autor: Farshid Rahimibashar, Ladan Sedighi, Alireza Shahriary, Zeljko Reiner, Mohamad Amin Pourhoseingholi, Golshan Mirmomeni, Ali Fathi Jouzdani, Amir Vahedian-Azimi, Tannaz Jamialahmadi, Amirhossein Sahebkar
Rok vydání: 2021
Předmět:
Zdroj: Clinical nutrition ESPEN. 49
ISSN: 2405-4577
Popis: Background: COVID-19 is an infectious disease which caused a pandemic with many diseases and fatalities. This new variant of coronavirus called SARS-CoV-2 and is primarily characterized by respiratory symptoms. There are some data indicating that LDL-cholesterol (LDL-C) as well as HDL-cholesterol (HDL-C) levels are inversely correlated to disease severity and could act as a predictor for disease progression and unfavorable prognosis. However, the results of some other studies do not confirm this. This current study aimed to provide an answer to this question. ----- Methods: This prospective, single-center study analyzed 367 confirmed COVID-19 patients to find whether there are any differences in plasma lipoproteins between survivors and non-survivors patients or between the patients with a "duration of ≤10 days intensive unit care (ICU) stay" and patients with a "duration of >10 days ICU stay". ----- Results: No association between any lipid/lipoprotein parameter and the severity of COVID-19 could be found but survivors and non-survivors did differ concerning total cholesterol and LDL-C levels. ----- Conclusion: Multivariate cox regression analysis could not prove any association between lipids/lipoproteins and severe events in COVID-19 patients. Significantly less non-survivors with COVID-19 were taking atorvastatin than survivors which is consistent with the majority of previous findings.
Databáze: OpenAIRE
Externí odkaz: